Using UNC's expertise to fight emerging diseases

Posted Jul 13, 2018
Gilead Sciences, Inc., and Carolina are teaming up to save lives. The biopharmaceutical company sought the University's resources and talents in the development of treatments to control disease outbreaks. Imagine: One drug with the potential to treat MERS, SARS, Ebola, and the common cold. At Carolina, researchers are imagining — and enabling — just that. (UNC.edu)

Related: Campus Connections

Video: IC Podcast - Touch 'Em All with Larry Keith
"Touch 'Em All: My Life and Career at Sports Illustrated" is Larry Keith's memoir about an accomplished writer and editor who began his career at...
Wed Nov 5, 2025

A guide to Chapel Hill's live music scene
Chapel Hill’s live music scene is bustling and evergreen. Music venues in Chapel Hill and Carrboro have shows almost every single night. Student musicians make...
Wed Nov 5, 2025

Ghosts of UNC's past and present
Every October, the whispers of UNC’s past seem to echo a little louder. For decades, students and staff have swapped legends of spirits that are...
Mon Nov 3, 2025

Residents flock to spooktacular Halloween celebration on Franklin Street
Hundreds of people flocked to Franklin Street on Friday to celebrate Halloween in Chapel Hill, North Carolina. The college town has been a popular spot...
Sat Nov 1, 2025